Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CBER
Biotech
FDA proposes higher fees for ph. 1 trials conducted outside of US
The proposal is designed to incentivize U.S. drug development by tacking on higher fees for those not running phase 1 trials in the country.
Gabrielle Masson
Dec 3, 2025 5:19pm
Former FDA official Peter Marks joins Eli Lilly
Oct 7, 2025 3:49pm
Takeda taps longtime Lilly exec as US head—Chutes & Ladders
Sep 12, 2025 8:30am
FDA proposes new approval pathway for rare diseases
Sep 3, 2025 1:20pm
Sanofi snags CMO from BioMarin—Chutes & Ladders
Aug 29, 2025 8:30am
Fierce Pharma
Vinay Prasad is back at the FDA after last month's surprise ouster
Aug 9, 2025 12:22pm
